home / stock / tryp / tryp quote
Last: | $3.74 |
---|---|
Change Percent: | 3.31% |
Open: | $3.67 |
Close: | $3.74 |
High: | $3.75 |
Low: | $3.67 |
Volume: | 76,761 |
Last Trade Date Time: | 07/19/2022 04:40:57 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.74 | $3.67 | $3.74 | $3.75 | $3.67 | 76,761 | 07-19-2022 |
$3.62 | $3.56 | $3.62 | $3.6999 | $3.56 | 45,621 | 07-18-2022 |
$3.555 | $3.46 | $3.555 | $3.58 | $3.46 | 33,820 | 07-15-2022 |
$3.485 | $3.52 | $3.485 | $3.52 | $3.46 | 3,298 | 07-14-2022 |
$3.5276 | $3.5199 | $3.5276 | $3.55 | $3.4589 | 29,019 | 07-13-2022 |
$3.535 | $3.41 | $3.535 | $3.55 | $3.41 | 56,756 | 07-12-2022 |
$3.46 | $3.5 | $3.46 | $3.5 | $3.45 | 3,237 | 07-11-2022 |
$3.54 | $3.57 | $3.54 | $3.57 | $3.5092 | 7,671 | 07-08-2022 |
$3.54 | $3.5588 | $3.54 | $3.5695 | $3.53 | 4,584 | 07-07-2022 |
$3.4557 | $3.47 | $3.4557 | $3.5101 | $3.43 | 10,560 | 07-06-2022 |
$3.52 | $3.39 | $3.52 | $3.52 | $3.39 | 49,384 | 07-05-2022 |
$3.52 | $3.48 | $3.52 | $3.52 | $3.46 | 9,052 | 07-04-2022 |
$3.52 | $3.48 | $3.52 | $3.52 | $3.46 | 9,046 | 07-01-2022 |
$3.4779 | $3.5 | $3.4779 | $3.5 | $3.4 | 16,374 | 06-30-2022 |
$3.53 | $3.59 | $3.53 | $3.59 | $3.505 | 14,585 | 06-29-2022 |
$3.61 | $3.66 | $3.61 | $3.67 | $3.61 | 7,484 | 06-28-2022 |
$3.623 | $3.67 | $3.623 | $3.67 | $3.62 | 15,246 | 06-27-2022 |
$3.66 | $3.45 | $3.66 | $3.6699 | $3.45 | 22,337 | 06-24-2022 |
$3.4983 | $3.51 | $3.4983 | $3.56 | $3.43 | 36,967 | 06-23-2022 |
$3.52 | $3.47 | $3.52 | $3.57 | $3.47 | 10,599 | 06-22-2022 |
News, Short Squeeze, Breakout and More Instantly...
SonicShares Airlines, Hotels, Cruise Lines ETF Company Name:
TRYP Stock Symbol:
NYSE Market:
KELOWNA, BC / ACCESSWIRE / March 12, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP)(OTCQB:TRYPF ) is pleased to announce that the Company's securityholders overwhelmingly approved the previously announced arrangement (the " Arrangement ") involving the Company and Exoph...
KELOWNA, BC / ACCESSWIRE / February 8, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP)(OTCQB:TRYPF ), a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet m...
KELOWNA, BC / ACCESSWIRE / January 26, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP )( OTCQB:TRYPF ), a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet...